Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC

This study has been completed.
Information provided by:
Sunesis Pharmaceuticals Identifier:
First received: November 9, 2005
Last updated: May 9, 2007
Last verified: January 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: April 2007
  Estimated Primary Completion Date: No date given